Back to results
US 7,078,177 B2Granted
Method of assaying for agonists or antagonist of Dynorphin A binding to the MAS receptor
AssigneeAstraZeneca AB
InventorsSultan Ahmad, Eric Grazzini, Paola Lembo
Life of this patent
Estimating the term…
Abstract
The present invention is directed to assays that can be used to screen for compounds that act as agonists or antagonists or inverse agonists of Dynorphin A and its analogues. The assays are based upon the binding of Dynorphin A and its analogues to the rat and human MAS receptors.
Claims4
A method for identifying a compound that is able to bind to the rat or human MAS receptor, comprising:
- a) providing a cell or membrane from a cell transformed with a heterologous rat or human MAS receptor gene, said cell expressing the rat or human MAS receptor;
- b) incubating the cell or membrane with Dynorphin A or Dynorphin A-amide or Dynorphin A 1-13 in the presence and absence of a test compound;
- and
- c) determining binding of Dynorphin A or Dynorphin A-amide or Dynorphin A 1-13 to the cell or membrane, wherein a decrease in binding in the presence of the compound as compared with binding in the absence or the compound indicates that the compound is able to bind to the rat or human MAS receptor.
1 more element
A method for identifying a compound that increases or decreases the activity of the rat or human MAS receptor, comprising:
- a) providing a cell or membrane from a cell transformed with a heterologous rat or human MAS receptor gene, said cell expressing the rat or human MAS receptor;
- b) incubating the cell or membrane with Dynorphin A or Dynorphin A-amide or Dynorphin A 1-13, and a test compound;
- c) determining intracellular concentration of calcium of said cell;
- and
- d) comparing the results obtained in step c) with the results obtained with a control in the absence or said test compound;
- wherein a change in intracellular concentration of calcium of said cell in the presence of said compound as compared with intracellular concentration of calcium of said cell in the absence of said compound indicates that said compound increases or decreases MAS receptor activity.
3 more elements
Dependencies are inferred from the claim text.